About Luspatercept
            
            Class: | Erythroid maturation agent  
Use: | Treatment of anemia in adult patients with beta-thalassemia who require regular red blood cell transfusions and in adult patients with myelodysplastic syndromes (MDS) associated with ring sideroblasts  
Adult dose: | 1 mg/kg administered subcutaneously every 3 weeks; may be increased to 1.5 mg/kg based on response and tolerability  
Pediatric dose: | Safety and efficacy not established in pediatric patients  
Side effects: | Fatigue, headache, arthral
         
        
            
                
                
                    
                        Drug Class
                    
                    Erythroid maturation agent
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of anemia in adult patients with beta-thalassemia who require regular red blood cell transfusions and in adult patients with myelodysplastic syndromes (MDS) associated with ring sideroblasts
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light; may be stored at room temperature (up to 25°C or 77°F) for up to 3 days
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Bristol Myers Pharmaceutical, IRELAND
                    
                    
                    Package Size
                    1 Glass Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 26433.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        1 mg/kg administered subcutaneously every 3 weeks; may be increased to 1.5 mg/kg based on response and tolerability
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Fatigue, headache, arthralgia, dizziness, hypertension, injection site reactions, and increased hemoglobin levels
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to luspatercept or any component of the formulation; pregnancy (Category X)
         
        
        
            
                Important Warnings
            
            Risk of thrombosis; monitor for signs and symptoms; may cause increased blood pressure; not for use in patients with uncontrolled hypertension; monitor hemoglobin levels regularly
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.